Who owns AVALO THERAPEUTICS INC?
- CUSIP Number: 05338f207
Tip: Access positions for across all investors
Analyze quarterly positions in Avalo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avalo Therapeutics stock
Who bought or sold AVALO THERAPEUTICS INC this quarter?
There are no current stakeholders of Avalo Therapeutics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Avalo Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Sep 2023 | 185k | $22k |
| Baader Bank | Sep 2023 | 184k | $20k |
| Vanguard Group | Sep 2023 | 92k | $11k |
| JustInvest | Sep 2023 | 37k | $4.5k |
| Level Four Advisory Services | Sep 2023 | 36k | $4.4k |
| Jane Street | Sep 2023 | 28k | $3.3k |
| Mariner Wealth Advisors | Sep 2023 | 19k | $2.2k |
| Two Sigma Securities | Sep 2023 | 16k | $1.9k |
| Wells Fargo & Company | Sep 2023 | 1.2k | $150.285100 |
| Royal Bank of Canada | Sep 2023 | 471.00 | $0 |
| Advisor Group Holdings | Sep 2023 | 347.00 | $0 |
| Fifth Third Bancorp | Sep 2023 | 279.00 | $34.010100 |
| FTB Advisors | Sep 2023 | 276.00 | $33.009600 |